International Patent: LAG-3 PROTEIN, PD-1 INHIBITOR AND CHEMOTHERAPY TRIPLE COMBINATION THERAPY

GENEVA, June 19 -- IMMUTEP S.A.S. filed a patent application (EP2025/082960) for “LAG-3 PROTEIN, PD-1 INHIBITOR AND CHEMOTHERAPY TRIPLE COMBINATION THERAPY”. With publication no. WO/2026/104573, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 39/395

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....